# How Long Ipamorelin Stays in Your System: Half-Life and Clearance > Ipamorelin: how long does ipamorelin stay in your system? Terminal half-life is about 2 hours in humans (IV), clearance 0.078 L/h/kg. The full pharmacokinetic picture, cited to source. About two hours to clear half, a single GH pulse near forty minutes, and a urine-detection window that outlasts both — the kinetics in full. ## The short version How long does ipamorelin stay in your system? In healthy human volunteers, the terminal half-life — the time for blood levels to fall by half once clearance is underway — was about 2 hours after an intravenous dose [2]. A rough rule of thumb in pharmacology is that a drug is mostly gone after four to five half-lives, which for Ipamorelin would put near-complete clearance in roughly 8 to 10 hours. The active effect is even shorter: the growth-hormone pulse it triggers peaks about 40 minutes after dosing and then fades [2]. One important wrinkle — "out of your bloodstream" and "undetectable in a drug test" are not the same thing. Anti-doping laboratories detect Ipamorelin and its breakdown products in urine well after the peptide itself has cleared the blood [11], which is why athletes are tested on metabolites, not the parent peptide. ## The human pharmacokinetic numbers The defining dataset comes from a population PK/PD study in healthy male volunteers given five single intravenous infusions spanning 4.21 to 140.45 nmol/kg over 15 minutes [2]. Three numbers summarize it: a terminal half-life of approximately 2 hours, a clearance of 0.078 L/h/kg, and a steady-state volume of distribution of 0.22 L/kg [2]. The kinetics were dose-proportional — exposure scaled linearly with dose across the whole range, with no surprises at the top end. That linearity matters because it means the compound's behavior is predictable: there is no evidence of saturation or accumulation within the studied single-dose range. This is one of the only human Ipamorelin datasets in existence, which is why nearly every credible half-life figure traces back to it. ## The single GH pulse: about forty minutes The pharmacodynamic half of the same study is just as clean. Rather than a broad, sustained rise, Ipamorelin produced a single discrete growth-hormone pulse that peaked at roughly 0.67 hours — about 40 minutes — after dosing [2]. This is the signature that makes the compound pharmacologically interesting: it mimics the body's own pulsatile GH rhythm, a brief spike followed by a return to baseline, rather than the flat elevation that older or cruder approaches produce. The pulse shape is downstream of the receptor mechanism — GHS-R1a activation drives a calcium-triggered GH release [1] — and it resolves on a timescale consistent with the ~2-hour clearance of the peptide that triggered it. ## What the animal kinetics add Rodent data fills in the metabolic-stability picture. In male rats, Ipamorelin showed roughly 5-fold lower systemic plasma clearance than GHRP-6, with 60-80% of the administered dose recovered intact in bile and urine — evidence of moderate metabolic stability, helped by the non-natural residues that resist enzymatic breakdown [10]. The same study measured an intranasal bioavailability of about 20%, meaningful but modest [10]. The greater stability versus GHRP-6 is consistent across the rat and human work and is part of why Ipamorelin was considered a more refined secretagogue than the earlier GHRPs. None of this changes the human half-life figure — it explains the molecular reasons behind it. ## Detection outlasts clearance For anyone thinking about Ipamorelin's status in sport, the detection window is the number that matters, and it is longer than the blood half-life. A comprehensive metabolism study identified at least three urinary metabolites of Ipamorelin, formed by exopeptidase, amidase, and endopeptidase activity, characterized by UHPLC-Orbitrap mass spectrometry [8]. High-throughput LC-MS/MS and solid-phase-extraction methods detect Ipamorelin and its metabolites in human and equine urine [9], and metabolite work after nasal administration underpins the accredited detection assays [11]. Ipamorelin is prohibited in sport at all times under WADA category S2, and these methods make that prohibition enforceable [11]. The peptide clears the blood in hours; the metabolite evidence in urine persists longer. ## Why the half-life is the whole design The two-hour half-life is not a footnote — it is the point of the molecule. A short, clean half-life paired with a single 40-minute GH pulse is exactly the profile a pulsatile-GH approach wants: deliver a transient signal, then get out of the way so the axis can reset [2]. It is why the studied regimens lean on repeated short exposures rather than continuous dosing (see [the dosage page](/dosage)), and it sets up the companion question of onset — covered on [how long does it take for ipamorelin to work](/how-long-to-work). Read together, the half-life and onset data describe a compound engineered around timing as much as potency. --- A pharmacokinetics-first reading of the Ipamorelin record — the two-hour half-life and the single forty-minute GH pulse logged before anything else, the failed human trial kept in plain view, and the community reports fenced off as unverified; no clinic wired behind the console and nothing here sourced, dosed, prescribed, or sold.